David R. Holmes Jr, MD; Michael J. Mack, MD
JAMA. 2019;321(11):1043-1044. doi:10.1001/jama.2019.1542
This Viewpoint discusses the strategy of “rational dispersion” for new technology into clinical practice, and proposes patient and clinical selection criteria, follow-up and registry surveillance, and regionalization strategies that would guide rational staged rollout of transcatheter technology for mitral valve repair (TMVR).
Mark Hew, MBBS, PhD, FRACP; Helen K. Reddel, MBBS, PhD, FRACP
free access
JAMA. 2019;321(11):1045-1046. doi:10.1001/jama.2019.1289
This Viewpoint discusses integration of sensors to metered dose inhalers (MDIs) that provide measures of actuation and adherence and calls on physicians and manufacturers to make monitor-derived adherence measures a standard component of management of asthma, chronic obstructive pulmonary disease (COPD), and other MDI-treated lung disease.
Suhas Gondi, BA; Zirui Song, MD, PhD
free access
JAMA. 2019;321(11):1047-1048. doi:10.1001/jama.2019.1077
This Viewpoint describes trends favoring private equity acquisition of health care practices and companies, and calls for research to better characterize potential risks and benefits relative to health care quality, outcomes, and costs.
Stavros G. Memtsoudis, MD, PhD, MBA; Jashvant Poeran, MD, PhD; Henrik Kehlet, MD, PhD
free access
JAMA. 2019;321(11):1049-1050. doi:10.1001/jama.2019.1070
This Viewpoint characterizes the evidence base underlying existing interventions to reduce complications and improve patient outcomes after surgery, and emphasizes the need for science to guide extension and development of new interventions in the face of pressures to use length-of-stay (LOS) as the primary measure of enhanced recovery and to use interventions shown effective for one population and setting to others.